Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Echometrix
AddedFeb 16, 2024
UpdatedJun 18, 2026
Echometrix

Echometrix

Angel

Echometrix: Global provider of ultrasound-based software, EchoSoft, for advanced, non-invasive evaluation of muscle injuries.

HQ
Fitchburg, WI, US
Founded
2007
Overview
Compare
Fundraising
Employees

Echometrix, founded to leverage the theory of acoustoelasticity (AE) for advanced biological material evaluation, focuses on developing ultrasound-based biomechanics products. Their flagship product, EchoSoft, is an analytical software that utilizes AE to offer non-invasive, functional assessments of ligament, tendon, and muscle injuries. The company aims to revolutionize medical imaging and biomechanics research by providing precise and comprehensive injury evaluations.

EchoSoft is now utilized globally by leading researchers in biomechanics and medical imaging. Echometrix has garnered attention for its innovative approach and significant contributions to non-invasive medical diagnostics. The company's impact is evident in its adoption by top-tier research institutions, enhancing the accuracy and efficiency of injury assessments worldwide.

Echometrix - Similar Companies

Echo Mind Ai logo

Echo Mind Ai

echomindai.com

Etiometry logo

Etiometry

etiometry.com

Echolase logo

Echolase

echolase.com

MuscleSound logo

MuscleSound

musclesound.com

Epsilon Imaging logo

Epsilon Imaging

JointMetrix Medical logo

JointMetrix Medical

MicroElastic Ultrasound Systems logo

MicroElastic Ultrasound Systems

microelastic.com

ZetrOZ Systems logo

ZetrOZ Systems

zetroz.com

SpinTech logo

SpinTech

Vital Metrix logo

Vital Metrix

OtoNexus Medical Technologies logo

OtoNexus Medical Technologies

otonexus.com

EchoNous logo

EchoNous

echonous.com

Physiosonics logo

Physiosonics

ZenoLink logo

ZenoLink

Verasonics logo

Verasonics

verasonics.com

Echometrix - Quick Facts

Who are Echometrix's competitors?

Companies similar to Echometrix include Echo Mind Ai, Etiometry, Echolase and MuscleSound.

When was Echometrix founded?

Echometrix was founded in 2007.

Where is Echometrix's headquarters located?

Echometrix's headquarters is located in Fitchburg, WI, US.

When was Echometrix's last funding round?

Echometrix's most recent funding round was for $92.4k (USD) in October 2014.

How much has Echometrix raised to-date?

As of Oct 6, 2014, Echometrix has raised a total of $1.4M (USD).

How many employees does Echometrix have?

Echometrix has 30 employees as of Feb 4, 2024.

Echometrix - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Medical Software
Tags
  • Biotech
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified